pharmaceuticals - Publications - Faculty & Research

13 Oct 2009
Research & Ideas

7 Lessons for Navigating the Storm

focused strategy that builds off your unique strengths. Step 4: Make vital investments during the downturn. Intel and Exxon offer evidence that you cannot wait to make vital investments you need to win in the emerging market. When it appeared growth was slowing in the... View Details

Keywords: by Martha Lagace

Research Summary

Career Histories and the Biotechnology Industry

Professor Higgins' other major project focuses on the consequences of individuals' career experiences for firms and industries. This second research stream centers on the careers of executives in the biotechnology industry.

Professor Higgins has written... View Details

15 Jun 2007
Research & Ideas

Remembering Alfred Chandler

Chemical and Pharmaceutical Industries. In his lifetime, he produced a range of books, edited collections, and articles covering railways, management, global competition, anthracite coal, the career of Alfred P. Sloan, the nature of... View Details

Keywords: by Sean Silverthorne

11 Sep 2019
Research & Ideas

Germany May Have the Answer for Reducing Drug Prices

the Poronui Associate Professor of Business Administration. Pharmaceutical companies have long opposed efforts to regulate drug prices, arguing that prices reflect the companies’ massive research investments. But Germany’s approach shows... View Details

Keywords: by Danielle Kost; Health

03 Dec 2001
Research & Ideas

Healthcare Conference Looks At Ailing Industry

specified stage of development. It would throw the ball over the fence [to a major pharmaceutical firm] and it would sit around and wait. Sooner or later, if the product was successful, it would collect some royalties." Now, a... View Details

Keywords: by Martha Lagace; Health

25 Apr 2005
Research & Ideas

New Learning at American Home Products

pharmaceutical companies in 1984, American Home Products ranked first in sales and twenty-eighth in R&D expenditures as a percentage of sales.23 As the historian Williams Haynes noted, by the end of the 1930s, American Home Products... View Details

Keywords: by Alfred D. Chandler Jr.; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical

15 Sep 2009
First Look

First Look: September 15

http://www.nber.org/papers/w11503 Synthesis by Microbes or Chemists? Pharmaceutical Research and Manufacturing in the Antibiotic Era Author:Arthur A. Daemmrich Publication:History and Technology 23, no. 3 (2009): 237-256 Abstract This... View Details

Keywords: Martha Lagace

10 Sep 2008
Research & Ideas

Long-Tail Economics? Give Me Blockbusters!

you can make money in many creative industries by selling specialized products to niche markets identified via the Internet. For example, the new CEO of GlaxoSmithKline, the pharmaceuticals giant, likens the search for blockbusters to... View Details

Keywords: by John Quelch; Pharmaceutical; Pharmaceutical

12 Dec 2022
Research & Ideas

Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them

Moderna, a pharmaceutical company, announced in September 2020 that it would slow enrollment of its COVID-19 vaccine trials to better improve representation. The majority of study participants were white, although COVID-19 was... View Details

Keywords: by Scott Van Voorhis; Pharmaceutical; Pharmaceutical

07 Aug 2000
Research & Ideas

The Business of Biotech

coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details

Keywords: by Julia Hanna; Biotechnology; Health; Technology

April 1995
Teaching Note

Evolving Finance Function, The: Judy C. Lewent at Merck & Co., Inc. (TN)

By: Timothy A. Luehrman

Teaching Note for (9-294-014). View Details

Keywords: Pharmaceutical Industry

Citation

Purchase

February 1990 (Revised January 1993)
Teaching Note

Merck-Banyu (TN)

By: Timothy A. Luehrman

Teaching Note for (9-287-061). View Details

Keywords: Pharmaceutical Industry

Citation

January–February 2023
Article

Data-Driven COVID-19 Vaccine Development for Janssen

By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan

The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details

Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry

Citation

Find at Harvard

Purchase

2023
Working Paper

Market Exclusivity and Innovation: Evidence From Antibiotics

By: Edward Kong and Olivia Zhao

The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details

Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States

Citation

SSRN

2024
Working Paper

Dusting Off the Old Ones: Drug Licensing to Startups, Innovation Success and Efficiency

By: Mosab Hammoudeh, Joshua Lev Krieger and Jiajie Xu

This paper investigates whether moving R&D from incumbents to startups can increase innovation. Using comprehensive drug development data, we examine the outcomes of drug projects licensed from large firms to startups. We find that these projects licensed to startups... View Details

Keywords: Product Development; Innovation and Invention; Business Startups; Research and Development; Performance Efficiency; Pharmaceutical Industry

Citation

Read Now

March 2023 (Revised March 2024)
Case

The Purdue Pharma Bankruptcy: Settling the Opioid Crisis

By: Kristin Mugford, Carin-Isabel Knoop and Susan Pinckney

How to get to a fair outcome for claimants in the Purdue Pharma bankruptcy given its significant role in the U.S. opioid crisis. View Details

Citation

Educators

Purchase

2021
Working Paper

Regulatory Approval and Expanded Market Size

By: Benjamin Berger, Amitabh Chandra and Craig Garthwaite

Regulatory review of new medicines is often viewed as a hindrance to innovation by increasing the hurdle to bring products to market. However, a more complete accounting of regulation must also account for its potential market expanding effects through quality... View Details

Keywords: New Medicines; Regulatory Approval; Health Care and Treatment; Research and Development; Governing Rules, Regulations, and Reforms; Markets; Expansion; Pharmaceutical Industry

Citation

Find at Harvard

Read Now

October 1996 (Revised February 1997)
Case

Upjohn Company, The: The Upjohn-Pharmacia Merger

By: Krishna G. Palepu and Amy P. Hutton

In August 1995, the Upjohn Co. and Pharmacia AB announced a "merger of equals." This case provides background information on the industry, the position of Upjohn, and Upjohn's rationale for the proposed merger. View Details

Keywords: Mergers and Acquisitions; Financial Statements; Business Strategy; Annual Reports; Pharmaceutical Industry

Citation

Educators

Purchase